Alpha Centric Advisors LLC Eli Lilly & CO Transaction History

Alpha Centric Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Mar 09, 2022	SELL	$180.55 - $233.54 $51,095 - $66,091	-283 Closed	0 $0
Q1 2021 Mar 09, 2022	SELL	$164.32 - $212.72 $1,478 - $1,914	-9 Reduced 3.08%	283 $53,000
Q4 2020 Mar 11, 2022	SELL	$130.46 - $172.63 $3,131 - $4,143	-24 Reduced 7.59%	292 $49,000
Q3 2020 Mar 11, 2022	SELL	$146.22 - $169.13 $4,094 - $4,735	-28 Reduced 8.14%	316 $47,000
Q2 2020 Mar 11, 2022	BUY	$136.42 - $164.18 $46,928 - $56,477	344 New	344 $56,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.